American Century Companies’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-201,741
| Closed | -$1.71M | – | 2837 |
|
|
2025
Q3 | $1.71M | Buy |
201,741
+140,130
| +227% | +$1.36M | ﹤0.01% | 2120 |
|
|
2025
Q2 | $694K | Sell |
61,611
-53,128
| -46% | -$488K | ﹤0.01% | 2419 |
|
|
2025
Q1 | $1.09M | Buy |
114,739
+708
| +0.6% | +$7.15K | ﹤0.01% | 2224 |
|
|
2024
Q4 | $1.28M | Sell |
114,031
-1,266,153
| -92% | -$22.3M | ﹤0.01% | 2173 |
|
|
2024
Q3 | $39M | Buy |
1,380,184
+66,680
| +5% | +$1.72M | 0.02% | 716 |
|
|
2024
Q2 | $25.1M | Sell |
1,313,504
-246,640
| -16% | -$6.3M | 0.02% | 850 |
|
|
2024
Q1 | $51.2M | Buy |
1,560,144
+81,897
| +6% | +$2.61M | 0.03% | 548 |
|
|
2023
Q4 | $48.8M | Buy |
1,478,247
+40,004
| +3% | +$1.13M | 0.03% | 507 |
|
|
2023
Q3 | $39.2M | Sell |
1,438,243
-52,155
| -3% | -$1.45M | 0.03% | 538 |
|
|
2023
Q2 | $45.2M | Buy |
1,490,398
+33,255
| +2% | +$1.08M | 0.03% | 481 |
|
|
2023
Q1 | $47.2M | Buy |
1,457,143
+168,602
| +13% | +$5.33M | 0.04% | 454 |
|
|
2022
Q4 | $36.2M | Buy |
1,288,541
+77,410
| +6% | +$2.22M | 0.03% | 516 |
|
|
2022
Q3 | $43.5M | Buy |
1,211,131
+1,191,982
| +6,225% | +$42M | 0.04% | 419 |
|
|
2022
Q2 | $588K | Sell |
19,149
-1,304
| -6% | -$38K | ﹤0.01% | 1862 |
|
|
2022
Q1 | $661K | Buy |
20,453
+2,300
| +13% | +$60.2K | ﹤0.01% | 1836 |
|
|
2021
Q4 | $502K | Buy |
18,153
+1,971
| +12% | +$56.5K | ﹤0.01% | 1924 |
|
|
2021
Q3 | $502K | Buy |
16,182
+1,657
| +11% | +$39.8K | ﹤0.01% | 1875 |
|
|
2021
Q2 | $307K | Buy |
+14,525
| New | +$291K | ﹤0.01% | 2065 |
|
|
2020
Q4 | – | Sell |
-35,443
| Closed | -$440K | – | 1984 |
|
|
2020
Q3 | $440K | Buy |
+35,443
| New | +$417K | ﹤0.01% | 1392 |
|
|
2020
Q1 | – | Sell |
-463,452
| Closed | -$4.19M | – | 1641 |
|
|
2019
Q4 | $4.19M | Sell |
463,452
-24,566
| -5% | -$200K | ﹤0.01% | 833 |
|
|
2019
Q3 | $3.51M | Sell |
488,018
-209,644
| -30% | -$1.5M | ﹤0.01% | 878 |
|
|
2019
Q2 | $5.55M | Buy |
697,662
+142,457
| +26% | +$1.69M | 0.01% | 806 |
|
|
2019
Q1 | $6.98M | Buy |
555,205
+115,442
| +26% | +$1.83M | 0.01% | 714 |
|
|
2018
Q4 | $8.77M | Buy |
+439,763
| New | +$10.2M | 0.01% | 633 |
|
|
2017
Q4 | – | Sell |
-269,696
| Closed | -$4.8M | – | 1301 |
|
|
2017
Q3 | $4.8M | Sell |
269,696
-19,530
| -7% | -$402K | ﹤0.01% | 860 |
|
|
2017
Q2 | $7.33M | Buy |
289,226
+127,110
| +78% | +$3.06M | 0.01% | 752 |
|
|
2017
Q1 | $3.62M | Buy |
162,116
+8,020
| +5% | +$154K | ﹤0.01% | 949 |
|
|
2016
Q4 | $2.28M | Sell |
154,096
-6,193
| -4% | -$122K | ﹤0.01% | 1016 |
|
|
2016
Q3 | $3.95M | Sell |
160,289
-122,693
| -43% | -$2.87M | ﹤0.01% | 936 |
|
|
2016
Q2 | $5.43M | Buy |
282,982
+94,751
| +50% | +$1.3M | 0.01% | 817 |
|
|
2016
Q1 | $1.99M | Sell |
188,231
-53,650
| -22% | -$554K | ﹤0.01% | 1002 |
|
|
2015
Q4 | $2.93M | Buy |
241,881
+20,445
| +9% | +$301K | ﹤0.01% | 958 |
|
|
2015
Q3 | $3.53M | Buy |
221,436
+32,161
| +17% | +$627K | ﹤0.01% | 918 |
|
|
2015
Q2 | $3.69M | Buy |
+189,275
| New | +$3.53M | ﹤0.01% | 929 |
|
Other funds holding EVH
CCM
RF
EC
American Century Companies's EVH Position: Q4 2025 in Review
American Century Companies sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 201,741 shares — an estimated $1.71M sold.
American Century Companies first reported a position in EVH in Q2 2015 and held it in 34 quarters. The position peaked at $51.2M in Q1 2024. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.
- American Century Companies reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
- American Century Companies sold 201,741 Evolent Health shares in Q4 2025, an estimated $1.71M.
- American Century Companies first reported a position in Evolent Health in Q2 2015 and held it in 34 quarters.
- American Century Companies's Evolent Health position peaked at $51.2M in Q1 2024.
- 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.
Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.